Physician

Matthew E Rutter, M.D.

According to 2025 Medicare claims, Matthew Rutter, M.D. (NPI: 1588650758) practices urology in the Bowling Green, KY market, with the plurality of this provider's patient population coming from Warren, KY. This provider's primary affiliated billing organization is GRAVES GILBERT CLINIC PLLC (NPI: 1114948288; TIN: 610700826) and primary practice location at 42104-5852. Rutter is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and GGC ValueCare LLC (ACO ID: A5611), participating under the MSSP model.

Rutter's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 882 traditional Medicare patients, billed 28,962 HCPCS/CPT codes, and received $413,544 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 1,785 prescription claims across 547 beneficiaries totaling $1,508,011 in drug costs, led by Xtandi (Enzalutamide). DME data shows 14 claims. Open Payments data shows 10 records totaling $417. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $256,047 to $413,544. Similarly, Part D prescription costs have moved sharply higher in recent years, from $107,910 to $1,508,011. In contrast, DME billing represents a smaller volume and declined steadily, from $1,305 to $384.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	766	14,912	$256,047
2016	898	17,646	$281,174
2017	991	21,489	$325,918
2018	830	22,044	$371,972
2019	897	29,565	$440,030
2020	917	20,431	$393,118
2021	976	22,574	$421,716
2022	883	21,958	$480,249
2023	924	22,519	$458,718
2024	882	28,962	$413,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	388	1,812	$107,910
2016	430	2,082	$122,074
2017	438	1,934	$108,883
2018	400	1,608	$138,584
2019	411	1,587	$296,760
2020	416	1,611	$632,955
2021	455	1,622	$915,813
2022	428	1,430	$709,972
2023	490	1,502	$939,452
2024	547	1,785	$1,508,011

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	198	$24,651
2016	N/R	221	$27,893
2017	N/R	212	$25,272
2018	N/R	190	$21,349
2019	N/R	241	$31,526
2020	N/R	162	$23,332
2021	N/R	108	$13,269
2022	N/R	110	$3,997
2023	N/R	106	$5,205
2024	N/R	14	$6,884

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	150	188	$150
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	160	205	$87
76770	Complete ultrasound scan behind abdominal cavity	188	221	$65
84153	Psa (prostate specific antigen) measurement, total	275	393	$18
81003	Automated urinalysis test	224	331	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	102	3,060	$1,385,255
Myrbetriq	Mirabegron	61	2,409	$34,934
Mirabegron Er	Mirabegron	12	900	$9,610
Tamsulosin Hcl	Tamsulosin Hcl	501	39,365	$7,180
Finasteride	Finasteride	249	20,740	$3,263

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	14	$6,884

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$417	PROGENICS PHARMACEUTICALS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew E. Rutter, M.D.?

Tedicare shows public-source Medicare data for Matthew E. Rutter, M.D. (NPI 1588650758), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew E. Rutter, M.D. have ACO affiliation data?

Matthew E. Rutter, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and GGC ValueCare LLC (MSSP, ACO ID A5611).

What billing organization is linked to Matthew E. Rutter, M.D.?

Matthew E. Rutter, M.D. is linked to GRAVES GILBERT CLINIC PLLC (billing NPI 1114948288) in the available physician profile data.

Does Matthew E. Rutter, M.D. have Open Payments data?

Matthew E. Rutter, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.